Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND

View source ↗

Summary

An ongoing clinical trial (MIND, NCT07282470) investigates epigenetic profiling and liquid biopsy to guide personalized treatment for patients with meningioma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Meningioma, Meningioma of Brain | Status: RECRUITING